Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Short-term Investments (2017 - 2019)

Historic Short-term Investments for Cogent Biosciences (COGT) over the last 3 years, with Q1 2019 value amounting to $8.0 million.

  • Cogent Biosciences' Short-term Investments rose 1931.0% to $8.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $8.0 million, marking a year-over-year increase of 1931.0%. This contributed to the annual value of $22.9 million for FY2018, which is 8062.41% up from last year.
  • Latest data reveals that Cogent Biosciences reported Short-term Investments of $8.0 million as of Q1 2019, which was up 1931.0% from $22.9 million recorded in Q4 2018.
  • Cogent Biosciences' 5-year Short-term Investments high stood at $47.7 million for Q2 2018, and its period low was $6.7 million during Q1 2018.
  • In the last 3 years, Cogent Biosciences' Short-term Investments had a median value of $17.8 million in 2017 and averaged $22.6 million.
  • In the last 5 years, Cogent Biosciences' Short-term Investments surged by 8062.41% in 2018 and then surged by 1931.0% in 2019.
  • Cogent Biosciences' Short-term Investments (Quarter) stood at $12.7 million in 2017, then surged by 80.62% to $22.9 million in 2018, then plummeted by 65.15% to $8.0 million in 2019.
  • Its last three reported values are $8.0 million in Q1 2019, $22.9 million for Q4 2018, and $37.8 million during Q3 2018.